Pekrul I - Search Results

1

Laboratory Monitoring in Emicizumab-Treated Persons with Hemophilia A.

Müller J, Pekrul I, Pötzsch B, Berning B, Oldenburg J, Spannagl M. Müller J, et al. Among authors: pekrul i. Thromb Haemost. 2019 Sep;119(9):1384-1393. doi: 10.1055/s-0039-1692427. Epub 2019 Jun 16. Thromb Haemost. 2019. PMID: 31203578 Free article. Review.

2

Laboratory testing in hemophilia: Impact of factor and non-factor replacement therapy on coagulation assays.

Peyvandi F, Kenet G, Pekrul I, Pruthi RK, Ramge P, Spannagl M. Peyvandi F, et al. Among authors: pekrul i. J Thromb Haemost. 2020 Jun;18(6):1242-1255. doi: 10.1111/jth.14784. Epub 2020 Apr 23. J Thromb Haemost. 2020. PMID: 32115865 Free article. Review.

3

Optimizing Platelet GPVI Inhibition versus Haemostatic Impairment by the Btk Inhibitors Ibrutinib, Acalabrutinib, ONO/GS-4059, BGB-3111 and Evobrutinib.

Denzinger V, Busygina K, Jamasbi J, Pekrul I, Spannagl M, Weber C, Lorenz R, Siess W. Denzinger V, et al. Among authors: pekrul i. Thromb Haemost. 2019 Mar;119(3):397-406. doi: 10.1055/s-0039-1677744. Epub 2019 Jan 27. Thromb Haemost. 2019. PMID: 30685871

4

Emicizumab in the Treatment of Acquired Haemophilia: A Case Report.

Möhnle P, Pekrul I, Spannagl M, Sturm A, Singh D, Dechant C. Möhnle P, et al. Among authors: pekrul i. Transfus Med Hemother. 2019 Apr;46(2):121-123. doi: 10.1159/000497287. Epub 2019 Mar 15. Transfus Med Hemother. 2019. PMID: 31191199 Free PMC article.

5

Persistent inhibitor in acquired haemophilia A: A case for emicizumab?

Ganslmeier M, Pekrul I, Heinrich DA, Angstwurm M, Spannagl M, Möhnle P. Ganslmeier M, et al. Among authors: pekrul i. Haemophilia. 2021 Jul;27(4):e502-e505. doi: 10.1111/hae.14225. Epub 2020 Dec 13. Haemophilia. 2021. PMID: 33314498 No abstract available.

6

Approximation of emicizumab plasma levels in emergency situations. A practical approach.

Pekrul I, Pfrepper C, Calatzis G, Giebl A, Siegemund A, Grützner S, Spannagl M. Pekrul I, et al. Haemophilia. 2021 Mar;27(2):e214-e220. doi: 10.1111/hae.14264. Epub 2021 Feb 1. Haemophilia. 2021. PMID: 33522651

7

A novel approach to laboratory assessment and reporting of platelet von Willebrand factor.

Kragh T, Pekrul I, Ott HW, Spannagl M, Möhnle P. Kragh T, et al. Among authors: pekrul i. Platelets. 2022 Feb 17;33(2):242-248. doi: 10.1080/09537104.2020.1869715. Epub 2021 Jan 11. Platelets. 2022. PMID: 33427003

8

Sensitive and specific assessment of recombinant von Willebrand factor in platelet function analyzer.

Pekrul I, Kragh T, Turecek PL, Novack AR, Ott HW, Spannagl M. Pekrul I, et al. Platelets. 2019;30(2):264-270. doi: 10.1080/09537104.2017.1420153. Epub 2018 Jan 10. Platelets. 2019. PMID: 29319374

9

[Anticoagulation in patients with COVID-19].

Pekrul I, Spannagl M, Nitschmann S. Pekrul I, et al. Internist (Berl). 2021 Nov;62(11):1253-1255. doi: 10.1007/s00108-021-01190-y. Epub 2021 Oct 12. Internist (Berl). 2021. PMID: 34636950 Free PMC article. German. No abstract available.

10

Health Care Transition of Adolescents and Young Adults with Haemophilia: the Situation in Germany and the Munich experience.

Bidlingmaier C, Olivieri M, Schilling FH, Kurnik K, Pekrul I. Bidlingmaier C, et al. Among authors: pekrul i. Hamostaseologie. 2020 Feb;40(1):97-104. doi: 10.1055/s-0039-3402804. Epub 2020 Jan 28. Hamostaseologie. 2020. PMID: 31994160 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

18 results

Search Page